Skip to main content

Table 7 Dose modification, discontinuation and treatment pauses

From: Perspectives of people living with idiopathic pulmonary fibrosis: a qualitative and quantitative study

 

Pirfenidone (Esbriet)

(n = 30)

Nintedanib (Ofev)

(n = 38)

I have never stopped, paused, or taken fewer doses of my antifibrotic medication

43%

37%

I occasionally skip a dose or pill(s) or have in the past

33%​

29%​

I have paused my antifibrotic for a period of time before restarting

13%​

26%​

I have consistently taken a lower dose/fewer pills of my antifibrotic than the full dose

10%​

16%​

I stopped taking my antifibrotic and switched to the other antifibrotic

10%​

5%​

I stopped my antifibrotic and have not started taking it again

7%​

16%​